Literature DB >> 20859437

Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?

John E Calfee.   

Abstract

Year:  2008        PMID： 20859437      PMCID： PMC2793928          DOI： 10.1200/JOP.0711501

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  4 in total

1.  Accountability for reasonableness.

Authors:  N Daniels
Journal:  BMJ       Date:  2000-11-25

2.  An ethical template for pharmacy benefits.

Authors:  Norman Daniels; J Russell Teagarden; James E Sabin
Journal:  Health Aff (Millwood)       Date:  2003 Jan-Feb       Impact factor: 6.301

3.  The emerging market dynamics of targeted therapeutics.

Authors:  John E Calfee; Elizabeth Dupré
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

4.  6-STEPPPs: A Modular Tool to Facilitate Clinician Participation in Fair Decisions for Funding New Cancer Drugs.

Authors:  George P Browman; Braden Manns; Neil Hagen; Carole R Chambers; Anita Simon; Shane Sinclair
Journal:  J Oncol Pract       Date:  2008-01       Impact factor: 3.840
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.